Perinatal outcome in monochorionic twin pregnancies complicated by amniotic fluid discordance without severe twin-twin transfusion syndrome

A Huber, W Diehl, L Zikulnig, T Bregenzer, B J Hackelöer, K Hecher, A Huber, W Diehl, L Zikulnig, T Bregenzer, B J Hackelöer, K Hecher

Abstract

Objectives: To assess the natural history and perinatal outcome in monochorionic diamniotic twin pregnancies with discordant amniotic fluid volume without signs of severe twin-twin transfusion syndrome (TTTS).

Methods: This was an observational study of 84 consecutive monochorionic twin pregnancies which did not meet the criteria for severe TTTS and endoscopic laser coagulation of placental anastomoses at initial presentation. The population was subdivided into two groups. Group 1 consisted of 64 pregnancies (median gestational age, 20.1 (range, 15.6-24.7) weeks) with amniotic fluid discordance and no signs of congestive heart failure in the twin with the larger amniotic fluid volume (Twin 1) and positive end-diastolic flow in the umbilical artery of the twin with the smaller amniotic fluid volume (Twin 2). Group 2 (median gestational age, 19.1 (range, 16.0-24.4) weeks) consisted of 20 pregnancies with amniotic fluid discordance and intrauterine growth restriction (IUGR) (abdominal circumference < 5th percentile) in combination with absent or reversed end-diastolic (ARED) flow in the umbilical artery of Twin 2. After exclusion of one patient from Group 1, who opted for termination of pregnancy, nine patients in Group 1 and one in Group 2 developed severe TTTS, and laser coagulation was offered. The remaining 54 pregnancies of Group 1 were compared with the remaining 19 pregnancies of Group 2.

Results: Fetuses in Group 1 showed significantly higher survival rates (overall survival, 100/108 (92.6%) vs. 23/38 (60%), P < 0.0001; survival of both fetuses, 49/54 (90.7%) vs. 9/19 (47.4%), P = 0.0002) and median gestational age at delivery (33.6, (range, 27.6-37.8) weeks vs. 32.0 (range, 26.9-36.3) weeks, P = 0.0457). Overall, there was a significantly higher incidence of complications, defined as necessity for intrauterine intervention, fetal or neonatal death or delivery prior to 32 weeks, in Group 2 (Group 1: 30/63 (47.6%); Group 2: 16/20 (80%), P = 0.0188).

Conclusions: Our data suggest that amniotic fluid discordance in monochorionic diamniotic twin pregnancies in combination with IUGR and umbilical artery ARED flow in one fetus represents an extremely high-risk constellation for adverse pregnancy outcome.

References

    1. Dubé J, Dodds L, Armson BA. Does chorionicity or zygosity predict adverse perinatal outcome in twins? Am J Obstet Gynecol 2002; 186: 579-583.
    1. Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH. The hidden mortality of monochorionic twin pregnancies. Br J Obstet Gynaecol 1997; 104: 1203-1207.
    1. Denbow ML, Cox P, Taylor M, Hammal DM, Fisk NM. Placental angioarchitecture in monochorionic twin pregnancies: Relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. Am J Obstet Gynecol 2000; 182: 417-426.
    1. Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH. Early prediction of severe twin-to-twin transfusion syndrome. Hum Reprod 2000; 15: 2008-2010.
    1. Diehl W, Hecher K, Zikulnig L, Vetter M, Hackelöer BJ. Placental vascular anastomoses visualized during fetoscopic laser surgery in severe mid-trimester twin-twin transfusion syndrome. Placenta 2001; 22: 876-881.
    1. Quintero R, Morales WJ, Allen MH, Bornick P, Johnson P, Krueger M. Staging of twin-twin transfusion syndrome. J Perinat 1999; 19: 550-555.
    1. Hecher K, Huber A, Diehl W, Hackelöer BJ. Outcome after endoscopic laser surgery in severe twin-twin transfusion syndrome: Experience with 300 procedures. Fetal Diagn Ther 2002; 17 (Suppl 1): 39.
    1. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004; 351: 136-144.
    1. Mari G, Roberts A, Detti L, Kovanci E, Stefos T, Bahado-Singh RO, Deter RL, Fisk NM. Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the international amnioreduction registry. Am J Obstet Gynecol 2001; 185: 708-715.
    1. Banek CS, Hecher K, Hackelöer BJ, Bartmann P. Long-term neurodevelopmental outcome after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2003; 188: 876-880.
    1. Hecher K, Plath H, Bregenzer T, Hansmann M, Hackelöer BJ. Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol 1999; 180: 717-724.
    1. Zikulnig L, Hecher K, Bregenzer T, Baez E, Hackelöer BJ. Prognostic factors in severe twin-twin transfusion syndrome treated by endoscopic laser surgery. Ultrasound Obstet Gynecol 1999; 180: 717-724.
    1. Snijders RJM, Nicolaides KH. Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994; 4: 34-48.
    1. Mari G, Detti L, Levi-D'Ancona R, Kern L. ‘Pseudo’ twin-to-twin transfusion syndrome and fetal outcome. J Perinatol 1998; 18: 399-403.
    1. Quintero RA, Dickinson JE, Morales WJ, Bornick PW, Bermudez C, Cincotta R, Yee Chan F, Allen MH. Stage-based treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol 2003; 188: 1333-1340.
    1. Pharoah POD, Adi Y. Consequences of in-utero death in a twin pregnancy. Lancet 2000; 355: 1597-1602.
    1. Quintero RA, Bornick PW, Morales WJ, Allen MH. Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation. Am J Obstet Gynecol 2001; 185: 689-696.
    1. Quintero R. Laser therapy for monochorionic diamniotic twin gestations affected by selective intrauterine growth retardation and absent end-diastolic velocity of the umbilical artery. Ultrasound Obstet Gynecol 2004; 24: 248.
    1. Gratacós E, Carreras E, Becker J, Lewi L, Enríquez G, Perapoch J, Higueras T, Cabero L, Deprest J. Prevalence of neurological damage in monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic umbilical artery flow. Ultrasound Obstet Gynecol 2004; 24: 159-163.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅